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Abstract
The objective is to study β-amyloid (Aβ) deposition in dementia with Lewy bodies (DLB) with
Alzheimer’s disease (AD) pathology (DLB/AD). The size frequency distributions of the Aβ deposits
were studied and fitted by log-normal and power-law models. Patients were ten clinically and
pathologically diagnosed DLB/AD cases. Size distributions had a single peak and were positively
skewed and similar to those described in AD and Down’s syndrome. Size distributions had smaller
means in DLB/AD than in AD. Log-normal and power-law models were fitted to the size distributions
of the classic and diffuse deposits, respectively. Size distributions of Aβ deposits were similar in
DLB/AD and AD. Size distributions of the diffuse deposits were fitted by a power-law model
suggesting that aggregation/disaggregation of Aβ was the predominant factor, whereas the classic
deposits were fitted by a log-normal distribution suggesting that surface diffusion was important in
the pathogenesis of the classic deposits.
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Introduction
The deposition of β-amyloid (Aβ) in the form of diffuse (‘pre-amyloid’), primitive (‘neuritic’),
and classic (‘densecored’) deposits is one of the pathological hallmarks of Alzheimer’s disease
(AD) and Down’s syndrome (DS) [1]. In AD and DS, Aβ deposits up to 150 μm in diameter
can be observed in single sections of the cerebral cortex [2-4]. The frequency distributions of
Aβ deposit size in AD and DS have a single peak (unimodal) and are positively skewed, i.e.
there are few deposits in the smallest size classes (<10 μm), maximum frequency occurs
between deposit diameters of 20 and 40 μm (the modal class), and the frequency of the larger
deposits declines exponentially with increasing size [2-4]. The size frequency distributions of
the Aβ deposits provide information on two aspects of AD pathology: (1) a more accurate
© Springer-Verlag 2009
R.A.Armstrong@aston.ac.uk.
NIH Public Access
Author Manuscript
Neurol Sci. Author manuscript; available in PMC 2010 December 1.
Published in final edited form as:
Neurol Sci. 2009 December ; 30(6): 471–477. doi:10.1007/s10072-009-0135-6.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
measure of neuronal damage than density measurements [5,6], and (2) the pathogenesis of the
deposits [2,3].
A statistical mechanics approach has been adopted to model the growth of Aβ deposits in AD
[7,8]. Two major processes have been identified: (1) addition and removal of protein molecules
(‘aggregation/disaggregation’) and (2) diffusion of substances into a deposit (‘surface
diffusion’) [7]. During aggregation, monomers of Aβ interact with each other to form more
complex oligomers resulting in growth of the deposit. By contrast, during disaggregation,
Aβ molecules are removed from a deposit by glial cells resulting in the shrinkage and ultimately
the clearance of a deposit. Hence, positive growth of an Aβ deposit occurs when there is an
imbalance between the processes of aggregation and disaggregation. By contrast, ‘surface
diffusion’ is a process by which additional molecular constituents are acquired by a protein
deposit by diffusion from the brain parenchyma [8,9]. Several proteins are known to be
incorporated into Aβ deposits in AD including amyloid-P, α-antichymotrypsin, complement
factors [10], and apolipoprotein E (Apo E) [11], and these additional constituents may influence
deposit growth and morphology. The processes of aggregation/disaggregation and surface
diffusion have a predictable effect on the size frequency distributions of the resulting Aβ
deposits [2,8]. Hence, the frequency distribution of the Aβ deposits can be described by a
‘power-law’ function if the processes of aggregation/disaggregation predominate over those
of surface diffusion and a ‘log-normal’ model if surface diffusion is the predominant factor
[8].
Aβ deposits also occur in a significant number of cases of dementia with Lewy bodies (DLB)
[12-14]. DLB is characterised pathologically by the presence of α-synuclein positive Lewy
bodies (LB) in the brain stem and/or cortical and limbic regions [15]. In some cases, the density
of cortical Aβ deposits may be similar to that of AD [12-14]. These cases are often described
as ‘mixed’ cases of DLB (DLB/AD) or the Lewy body variant (LBV) of AD and combine
many of the features of DLB and AD [16]. Hence, the objectives of the present study were to
determine in DLB/AD: (1) whether the size distributions of the diffuse, primitive, and classic
Aβ deposits in the temporal lobe were similar to those described previously in ‘pure’ AD [2,
3,17] and (2) whether a log-normal distribution or a power-law model could account for the
size distributions.
Materials and methods
Cases
Brain tissue from ten male cases of DLB/AD was obtained from the Brain Bank, Department
of Neuropathology, Institute of Psychiatry, King’s College London, UK (Table 1). Cases were
not a random selection of the DLB cases available but were chosen for their high densities of
Aβ deposits. There is a gender imbalance in DLB towards males [15] but the all male sample
is a reflection of the small number of cases employed in the study. A summary of the clinical
features at presentation and occurring during the course of the disease together with the mini-
mental status exam (MMSE) score at death are given in Table 2. Memory impairments were
observed at presentation in 7/10 patients and significant Parkinson’s disease (PD) symptoms
were present at some stage of the disease in 5/10 patients. Disease onset was identified as the
time the first symptoms of the disease appeared and not the appearance of dementia. After
death, the consent of the next of kin was obtained for brain removal, following local Ethical
Committee procedure and the 1995 Declaration of Helsinki (as modified Edinburgh, 2000).
DLB cases were diagnosed according to the ‘Consortium on Dementia with Lewy
bodies’ (CDLB) guidelines [15]. In addition, all cases had sufficient densities of Aβ deposits
(Table 1) for a diagnosis of DLB/AD according to the ‘Consortium to Establish a Registry of
Alzheimer’s disease’ (CERAD) criteria [18]. These cases also had significant numbers of
cortical neurofibrillary tangles (NFT) (Table 1). Size frequency distributions of Aβ deposits
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in DLB/AD were compared with previously published data for ten cases of sporadic AD [3,
4,17]. The mean age at death of AD cases (3 male:7 female) was 81.8 years (SD = 8.51), mean
duration of disease was 7.0 years (SD = 3.31), and the MMSE at death was in the range 0–5).
Tissue preparation
A block of the temporal lobe, at the level of the lateral geniculate body, was taken from each
case and included the inferior temporal gyrus (ITG), lateral occipitotemporal gyrus (LOT), the
parahippocampal gyrus (PHG), hippocampus (HC), and dentate gyrus (DG). Tissue was fixed
in 10% phosphate buffered formal-saline and embedded in paraffin wax; 7 μm coronal sections
were stained with a rabbit polyclonal antibody (Gift of Prof. B.H. Anderton, Institute of
Psychiatry, King’s College London) raised to the 12–28 amino acid sequence of the Aβ protein
[19]. The antibody was used at a dilution of 1 in 1,200 and the sections incubated at 4°C
overnight. Sections were pretreated with 98% formic acid for 6 min which enhances Aβ
immunoreactivity. Aβ was visualised using the streptavidin–biotin horseradish peroxidase
procedure with diaminobenzidine as the chromogen. Sections were also stained with
haematoxylin. Aβ deposits are usually divided into three subtypes [20,21]: (1) diffuse deposits
are 10–200 μm in diameter, lightly stained, irregular in shape, and with diffuse boundaries, (2)
primitive deposits are 20–60 μm, well demarcated, symmetrical in shape, and strongly stained,
and (3) classic deposits are 20–100 μm had a distinct amyloid core surrounded by a ‘corona’
in which Aβ is located adjacent to dystrophic neurites.
Morphometric methods
In the ITG, LOT, and PHG, randomly located guidelines were marked on the slide extending
from the pia mater to the white matter. The greatest diameter of all Aβ deposits, greater than
5 μm in diameter, and which touched a guideline, were measured at ×400 using an eyepiece
micrometer. In the HC, all deposits from sectors CA1 to CA4 inclusive were measured and in
the DG, all deposits within the molecular layer. Data from the ten cases were combined to
construct a size frequency distribution of the diffuse, primitive, and classic Aβ deposits for
each brain region.
Data analysis
A log-normal distribution and a power-law function were fitted to the size distributions using
STATISTICA software (Statsoft Inc., 2300 East 14th St, Tulsa, OK 74104, USA). First, the
log-normal distribution was fitted to each size distribution and is defined as that of a variable
X such that ln (X – Ø) is normally distributed. This distribution has three parameters: a constant
Ø (where X > Ø), the mean μ, and the variance r2. In many applications, the value of Ø can be
assumed to be zero and a two-parameter model fitted to the data. Deviations from a log-normal
model were tested using the Kolmogorov–Smirnov (KS) goodness of fit test. Second, a variable
(Y) is distributed as a power-law function of X if the dependent variable has an exponent a, i.e.
a function of the form Y = CX−a. If a function of this type fits the data, a plot of log Y against
log X should yield a linear relationship. Hence, Aβ deposit sizes were grouped into size classes
and the log of the frequency of the Aβ deposits in each class plotted against the log of the upper
size limit of the size class. A linear regression was fitted to the data and the goodness of fit to
a linear model tested using Pearson’s correlation coefficient (r). In addition, χ2 contingency
table tests were used to compare the size frequency distributions of Aβ deposits between
different regions of the temporal lobe [6]. The degree of correlation (Pearson’s r) was also
calculated between the modal size class of the Aβ deposits in cortical, hippocampal, and dentate
gyrus regions of the individual patients and disease duration.
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Results
The size frequency distributions of the diffuse and classic Aβ deposits in the LOT in DLB/AD
are shown in Figs. 1 and 2. Both distributions had a single peak and exhibited a significant
degree of positive skew, i.e. with the mode to the left (P < 0.01). There were few deposits in
the smallest size class, the mode occurred at an upper size class limit of approximately 40 μm
for the diffuse deposits (Fig. 1) and 30 μm for the classic deposits (Fig. 2), and the frequency
of the larger deposits declined with increasing size.
The distribution statistics for all the Aβ populations studied is shown in Table 3. All size
distributions were unimodal and, with the exception of the classic Aβ deposits in the ITG,
exhibited a significant degree of positive skew. Differences in size distributions were apparent
both between deposit subtypes and brain region. First, in the ITG, LOT, and PHG, and CA
sectors of the HC, the primitive deposits had smaller means and were less skewed than the
diffuse and classic deposits. Second, the distribution of the diffuse deposits in the CA sectors
of the HC had a larger mean and was more significantly skewed than in the ITG and LOT.
Third, the size distributions of the primitive deposits in the CA sectors and DG molecular layer
had larger means and were more skewed than in the ITG, LOT, and PHG.
Figures 1 and 2 also show the fitted log-normal distributions. The observed size distribution
of the diffuse deposits (Fig. 1) deviated significantly from a log-normal model (KS = 0.10, P
< 0.01). There were fewer diffuse deposits in size classes smaller than the mode, more in the
modal class, and fewer larger than the mode than expected from the model. The distribution
of the classic deposits (Fig. 2) did not deviate significantly from a log-normal model (KS =
0.09, P > 0.05). An example of fitting the power-law model to the size distribution of the diffuse
deposits in the LOT is shown in Fig. 3. There was a significant linear decline in log frequency
with log size class (r = −0.75, P < 0.01) suggesting the size distribution did not deviate
significantly from a power-law model.
The results of fitting the log-normal distribution and power-law function to data from all brain
regions is shown in Table 4. The frequency distributions of the diffuse and primitive deposits
in the ITG, LOT, and PHG deviated significantly from a log-normal model, whereas the
frequency distribution of the classic deposits was consistent with a log-normal model. In
addition, the diffuse deposits in the ITG, LOT and PHG and the primitive deposits in the CA
sectors of the hippocampus were fitted successfully by a power-law function.
The degree of correlation (Pearson’s r) between the modal size class of the Aβ deposits in
cortical, hippocampal, and dentate gyrus regions of individual patients, and disease duration
is shown in Table 5. Modal size class of the diffuse and classic deposits was positively
correlated with duration of disease in cortical regions and the hippocampus, respectively. By
contrast, the primitive and classic deposits were not significantly correlated with disease
duration in the cortex and the diffuse and primitive deposits were either not significantly
correlated or possibly even negatively correlated with disease duration in the CA sectors of the
hippocampus.
Discussion
The first objective was to determine whether the size distributions of Aβ deposits in DLB/AD
were similar to those in AD. A summary of the size frequency distributions of Aβ deposits for
the previously published AD group [3,4,17] is given in Table 6. Comparison between groups
is complicated by the differences in mean age and especially gender distribution in the AD and
DLB/AD groups and because the DLB cases were not a random sample of those available. In
particular, the DLB group comprises all males while the AD group has a mixture of males and
females. Furthermore, the all male DLB sample reflects the lack of representativeness of the
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sample and not the fact that females with DLB have less Aβ deposition. In addition, although
the two groups have similar duration of disease (mean duration 8 years, SD = 6.0) compared
with AD (mean duration 7 years, SD = 3.3), disease onset in the DLB/AD group represents the
appearance of any of the symptoms characteristic of DLB and not the onset of dementia as in
AD.
Nevertheless, the size distributions of the Aβ deposits in DLB/AD had similarities with those
in AD. First, the size frequency distributions in DLB/AD were unimodal and positively skewed
and similar in shape to those in AD [2,3,17]. Second, as in AD, the size distributions of the
classic and diffuse deposits had larger means and exhibited a greater degree of skew than the
primitive deposits. With the exception of the CA sectors of the HC, however, the size
distributions in DLB/AD had smaller means than in AD. Although there is evidence that the
rate of progression of disease may be faster in DLB than in AD [22], Aβ deposition might be
associated with the onset of dementia and this may occur later in the course of the disease in
DLB/AD.
The second objective was to determine whether a lognormal or a power-law model fitted the
size distributions. In the ITG, LOT, and PHG a power-law model successfully fitted the size
distributions of the diffuse deposits. In AD and DS, diffuse deposits aggregate around clusters
of neuronal cell bodies [23-25]. Development of diffuse deposits may therefore involve first,
secretion of Aβ monomers from clusters of adjacent neuronal perikarya; second, the association
of Aβ monomers to form more complex oligomers, and third, the formation of an aggregated
deposit [25,26]. Disaggregation within a developing deposit may also occur as a result of the
removal of Aβ monomers by glial cells embedded within and present at the periphery of many
diffuse deposits [27]. Hence, an imbalance between aggregation and disaggregation is likely
to be the predominant factor in the formation of the diffuse deposits. The positive correlation
between the size of the modal class of Aβ deposits in cortical areas and disease duration is
consistent with growth of diffuse deposits over time. A successful fit to a power-law model
also implies that surface diffusion was less important in diffuse deposits. Fewer additional
molecular constituents have been recorded in diffuse compared with classic Aβ deposits in AD
consistent with this suggestion [21].
In the ITG, LOT, and PHG, a log-normal model provided a more successful fit to the size
distributions of the classic deposits as previously reported in AD and in DS [2]. In AD, the
classic deposits often aggregate around the larger diameter arterioles and substances leaking
from damaged blood vessels, may be incorporated into the deposits by surface diffusion [28].
A number of additional substances have been found within classic deposits including
immunoglobulins, amyloid-P, α1-antichymotrypsin, antitrypsin, antithrombin III, complement
factors and apo E consistent with diffusion [21]. Some of these substances may have
‘chaperone-like’ activity and influence the development of the deposit by enhancing the
aggregation of Aβ monomers [29,30] or encouraging the condensation of the amyloid to form
a dense core [21].
In the ITG, LOT, and PHG neither the log-normal nor power-law models fitted the size
distributions of the primitive deposits. By contrast, in the CA sectors of the hippocampus, the
size distribution of the primitive deposits was fitted by a power-law model while in the
molecular layer of the dentate gyrus, both models provided a fit to the data. Hence, the
pathogenesis of the primitive deposits appears to be complex and both aggregation/
disaggregation and surface diffusion, together with currently unidentified factors involved in
pathogenesis.
Modal size class of the diffuse and classic deposits was positively correlated with duration of
disease in cortical regions and the hippocampus, respectively. By contrast, the primitive and
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classic deposits were not significantly correlated with disease duration in the cortex and the
diffuse and primitive deposits were either not significantly correlated or possibly even
negatively correlated with disease duration in the CA sectors of the hippocampus. These results
suggest that the pattern of growth and development of the Aβ deposits depends both on deposit
type and brain region. Hence, the best evidence for growth of deposits over time is shown by
the diffuse deposits in the cortex and classic deposits in the hippocampus. By contrast, the size
of the primitive deposits was not significantly correlated with duration in any of the brain
regions studied and may even be negatively correlated. It is possible that the primitive deposits
are formed much more rapidly than the diffuse and classic types and once formed change little
or even shrink in size with time.
In conclusion, the size distributions of Aβ deposits in cases of DLB/AD were unimodal and
positively skewed and similar, apart from a smaller mean size, to those of AD. Size distributions
of the diffuse deposits were fitted by a power-law model suggesting that aggregation/
disaggregation of Aβ was the predominant factor, whereas the classic deposits were fitted by
a log-normal distribution suggesting that surface diffusion was important.
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Fig. 1.
The size frequency distributions of the diffuse β-amyloid (Aβ) deposits in the lateral
occipitotemporal gyrus (LOT) in a case of dementia with Lewy bodies with associated
Alzheimer’s disease pathology. The fitted curve represents the log-normal distribution (KS =
0.10, P < 0.05)
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Fig. 2.
The size frequency distributions of the classic β-amyloid (Aβ) deposits in the lateral
occipitotemporal gyrus (LOT) in a case of dementia with Lewy bodies with associated
Alzheimer’s disease pathology. The fitted curve represents the log-normal distribution (KS =
0.09, P > 0.05)
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Fig. 3.
Goodness of fit of the diffuse β-amyloid (Aβ) deposits in the lateral occipitotemporal gyrus
(LOT) to a power-law model (r = −0.75, P < 0.01)
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Table 4
Size class frequency distributions of β-amyloid (Aβ) deposits in dementia with Lewy bodies with associated
Alzheimer’s disease (AD) pathology (DLB/AD)
Brain region Aβ subtype Dev. from log-normal
model (KS)
Fit to power-law
model (‘r’)
ITG Diffuse 0.11** −0.80*
Primitive 0.17** −0.69 (NS)
Classic 0.12 (NS) −0.68 (NS)
LOT Diffuse 0.10** −0.75**
Primitive 0.13** −0.66 (NS)
Classic 0.09 (NS) −0.57 (NS)
PHG Diffuse 0.11** −0.67*
Primitive 0.18** −0.56 (NS)
Classic 0.09 (NS) −0.13 (NS)
HC Diffuse 0.08 (NS) −0.54 (NS)
Primitive 0.11** −0.78**
DG Primitive 0.10 (NS) −0.78*
Fit to log-normal and power-law functions in each brain region
ITG Inferior temporal gyrus
LOT lateral occipitotemporal gyrus, PHG parahippocampal gyrus, HC hippocampus (CA1–CA4), DG dentate gyrus, KS Kolmorogorov–Smirnov
statistic, r = Pearson’s correlation coefficient, NS not significant
*
P < 0.05;
**
P < 0.01
Neurol Sci. Author manuscript; available in PMC 2010 December 1.
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
N
IH
-PA Author M
anuscript
Armstrong and Cairns Page 15
Table 5
Correlations (Pearson’s r) between the modal size class of the Aβ deposits in cortical, hippocampal, and dentate
gyrus regions of individual patients and disease duration
X variable Aβ deposit Cortex Hippocampus Dentate gyrus
Disease Diffuse 0.49* −0.53 -
Duration Primitive −0.21 −0.49 −0.40
Classic 0.34 0.88** -
*
P < 0.05
**
P < 0.01
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